Objective: Although recent studies have shown that 30-day readmissions following sepsis are common, the overall fiscal impact of these rehospitalizations and their variability between hospitals relative to other high-risk conditions, such as congestive heart failure and acute myocardial infarction, are unknown. The objectives of this study were to characterize the frequency, cost, patient-level risk factors, and hospital-level variation in 30-day readmissions following sepsis compared with congestive heart failure and acute myocardial infarction. Design: A retrospective cohort analysis of hospitalizations from 2009 to 2011. Setting: All acute care, nonfederal hospitals in California. Patients: Hospitalizations for sepsis (n = 240,198), congestive heart failure (n = 193,153), and acute myocardial infarction (n = 105,684) identified by administrative discharge codes. Interventions: None. Measurements and Main Results: The primary outcomes were the frequency and cost of all-cause 30-day readmissions following hospitalization for sepsis compared with congestive heart failure and acute myocardial infarction. Variability in predicted readmission rates between hospitals was calculated using mixed-effects logistic regression analysis. The all-cause 30-day readmission rates were 20.4%, 23.6%, and 17.7% for sepsis, congestive heart failure, and acute myocardial infarction, respectively. The estimated annual costs of 30-day readmissions in the state of California during the study period were $500 million/yr for sepsis, $229 million/yr for congestive heart failure, and $142 million/yr for acute myocardial infarction. The risk-and reliabilityadjusted readmission rates across hospitals ranged from 11.0% to 39.8% (median, 19.9%; interquartile range, 16.1-26.0%) for sepsis, 11.3% to 38.4% (median, 22.9%; interquartile range, 19.2-26.6%) for congestive heart failure, and 3.6% to 40.8% (median, 17.0%; interquartile range, 12.2-20.0%) for acute myocardial infarction. Patient-level factors associated with higher odds of 30-day readmission following sepsis included younger age, male gender, Black or Native American race, a higher burden of medical comorbidities, urban residence, and lower income. Conclusion: Sepsis is a leading contributor to excess healthcare costs due to hospital readmissions. Interventions at clinical and policy levels should prioritize identifying effective strategies to reduce sepsis readmissions.
D ecreasing rates of hospital readmissions has emerged as an important approach to improving the quality and efficiency of healthcare delivery (1, 2) . The Centers for Medicare and Medicaid Services (CMS) began publicly reporting 30-day hospital readmission rates for common conditions, including acute myocardial infarction (AMI), congestive heart failure (CHF), and community-acquired pneumonia (CAP), as an incentive for healthcare organizations to improve care delivery and lower costs (1, 3) . Furthermore, the Patient Protection and Affordable Care Act has brought 30-day readmissions to the forefront of healthcare priorities by requiring CMS to reduce payments to hospitals that have excess readmissions for these diagnoses.
In the United States, there are approximately 700,000 cases of sepsis annually, resulting in an economic burden of approximately $15-24 billion (4) (5) (6) (7) (8) . Although recent studies have shown that 30-day readmissions following sepsis are common, the overall fiscal impact of these rehospitalizations, the risk factors for readmissions, and their variability between hospitals relative to other high-risk conditions are unknown (9) (10) (11) (12) . Understanding these factors is critical to assessing whether sepsis readmissions are mutable and whether interventions that reduce these rehospitalizations will substantively Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website (http://journals.lww.com/ccmjournal).
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For information regarding this article, E-mail: dchang@labiomed.org Rehospitalizations Following Sepsis: Common and Costly* improve the global readmissions problem. Thus, the goals of this study were to 1) estimate the frequency and cost of 30-day readmissions following hospitalization for sepsis compared with CHF and AMI, 2) examine the variability of risk-adjusted 30-day readmission rates between hospitals, and 3) identify the patient-level risk factors, which can inform the development of future interventions that reduce readmissions after sepsis.
MATERIALS AND METHODS

Data Source
Data for this study were obtained from the Healthcare Cost and Utilization Project (HCUP) State Inpatient Database (SID) maintained by the Agency for Healthcare Research and Quality (AHRQ) (13) . We focused analyses on data from California, as it is a large, ethnically diverse state with readmissions data reported annually in the SID. Discharge and visit records from the SID include de-identified information on patient demographics, expected payer, ZIP code of residence, diagnosis and procedure codes, admission source, disposition after hospitalization, length of stay, total charge for hospitalization, and hospital identification code. Cost of each hospitalization was calculated from total charges using hospital-specific costto-charge ratios provided by HCUP (13, 14) . The hospital-level cost-to-charge ratios were merged with the SID database by the hospital identification code, and the total costs were estimated by multiplying the total charges with the cost-to-charge ratio for each calendar year. The costs were adjusted to 2011 using the medical component of the Consumer Price Index (15) . Hospital characteristics were obtained by linking the SID database with California Office of Statewide Health Planning and Development (OSHPD) Patient Discharge Pivot Database by hospital identification codes ("DHOSPID" in the SID to "oshpd_id" in the OSHPD Patient Discharge Pivot Database) for each calendar year (16) .
Study Design
This was a retrospective cohort study of adult patients (age > 18) who were hospitalized in California for sepsis, CHF, and AMI during 2009-2011. Hospitalizations for sepsis were identified based on the presence of a compatible International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) code as the principal diagnosis for hospital admission. The ICD-9-CM codes that were used for sepsis were based on the Martin implementation: 038 (septicemia), 020.0 (septicemic), 790.7 (bacteremia), 117.9 (disseminated fungal infection), 112.5 (disseminated Candida infection), and 112.81 (disseminated fungal endocarditis). These codes have been previously used in population-based studies of sepsis, and the 038 code was found to have a positive predictive value of 97.7% and a negative predictive value of 80.0% using the clinical definition of sepsis as the gold standard (7, 17) . In our study population, 98.5% of the sepsis hospitalizations were identified based on the 038 code. For sensitivity analysis, we also examined the frequency, cost, and risk factors of 30-day readmissions in 2011 using the Angus implementation to identify hospitalizations for severe sepsis (4) . The ICD-9-CM codes used to define the cohorts with CHF (402.01, 402. 11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428 .XX) and AMI (410.XX) were consistent with the definitions used in the CMS reporting program and in previous studies (18) (19) (20) .
Patients were excluded from the analysis if they were hospitalized at a non-acute care facility, younger than 18 years, out-of-state residents, or missing information on length of stay or the unique encrypted patient identifier used in the HCUP database (VisitLink). Hospitals that reported less than 10 annual hospitalizations for sepsis, CHF, or AMI were excluded for analyses of each condition. For calculating index admissions for 30-day readmissions, hospitalizations occurring in December of each year were excluded to allow a 30-day window for rehospitalization. Similarly, for calculation of 90-day readmission rates, hospitalizations occurring in October, November, and December were excluded. The study was approved as an exempt protocol by the institutional review board at Los Angeles Biomedical Research Institute.
Statistical Analysis
Outcomes. The primary outcome was the all-cause 30-day readmission rate following hospitalization for sepsis. The unit of analysis was individual hospitalizations. The 30-day readmission rate for sepsis was calculated by dividing the number of hospitalizations with at least one subsequent hospital stay within 30 days of an index hospitalization by the total number of index hospitalizations for sepsis (21) . Index hospitalizations were defined as all hospital admissions with a primary diagnosis of sepsis that did not result in transfer to another acute care hospital or patient death. Hospitalizations resulting in a transfer to another hospital were excluded because in the SID database if a patient is admitted to one hospital and transferred to another facility, two hospitalization records are created (one for each hospital). We felt that despite being hospitalized at two separate facilities, this should be analyzed as one hospitalization with 30-day readmissions being ascribed to the discharging hospital. With the exception of the first hospitalization in each calendar year, hospitalizations were eligible to be both an index hospitalization for future readmissions and a readmission for a prior hospitalization. Similar approaches were used to calculate the 30-day readmission rates for CHF and AMI. We chose to compare sepsis with CHF and AMI because these, along with CAP, are among the high-risk conditions that are tracked in the CMS Readmissions Reduction Program. We did not compare sepsis with CAP in our study because these conditions are not mutually exclusive, and coding patterns for sepsis and CAP are likely to vary between hospitals and over time (22) . Length of stay, hospital mortality, and costs of hospitalization were calculated for all hospitalizations, index hospitalizations, and 30-day readmissions for sepsis, CHF, and AMI. Because length of stay and costs of hospitalization were not normally distributed, both medians and means are presented.
Causes of Readmissions. The most common diagnoses on readmission following sepsis were identified based on the primary Clinical Classification Software (CCS) code for each rehospitalization, which collapses ICD-9-CM codes into clinically meaningful categories (23) . The cumulative frequencies of the 20 most common CCS primary diagnosis codes for 7, 14, 30, and 90-day readmissions were examined for longitudinal changes in causes of readmission. We further consolidated the CCS diagnoses into seven clinical categories (infection, pulmonary, complications of care, cardiovascular, renal/genitourinary, gastrointestinal) to facilitate more meaningful data interpretation. The CCS diagnoses included in each clinical category are provided in Supplemental Table 1 (Supplemental Digital Content 1, http://links.lww.com/CCM/B362).
Risk Factors for 30-Day Readmissions. To examine the relationship between patient-and hospital-level factors and 30-day readmissions following sepsis, we generated hierarchical mixed-effects logistic regression models using presence of a 30-day readmission compared with no 30-day readmission as the dependent variable. The independent variables in the model were hospital-associated factors (number of beds, teaching status, proportion of minority patients, and hospital type), patient factors (age, ethnicity/race, gender, median income, rural or urban residence, and comorbid conditions), and healthcare systems and hospitalization-related factors (payer status, disposition after hospitalization, and length of stay). Comorbid conditions were identified using discharge data codes to calculate a Charlson comorbidity index (24) (25) (26) . The proportion of racial and ethnic minority patients seen by each hospital was estimated from the number of Black, Hispanic, Asian, and Native American patients admitted compared with total number of hospital admissions. Individual hospitals were used as random effects in the models to adjust for clustering of hospitalizations. We generated separate models for sepsis (model 1), CHF (model 2), and AMI (model 3) using the same dependent and independent variables to examine whether the patient-and hospital-level associations identified in the models are specific to each disease or more broadly applicable to odds of 30-day readmissions. Performance of each model was assessed by the c-statistic, calculated as the area under the receiver operating characteristic curve based on fitted probabilities from the model and the true values. The data are presented as adjusted odds ratios (ORs) with 95% CIs. Adjusted ORs with a 95% CI excluding 1.00 were considered statistically significant.
Hospital-Level Variation in 30-Day Readmissions.
To assess variation in readmission rates across hospitals, we created hierarchical logistic regression models to estimate the 30-day readmission rates for sepsis, CHF, and AMI in each hospital. We adjusted for case-mix by adding age and medical comorbidities as fixed effects and used individual hospitals as the random effect. These models were different than the models used to examine the association between patient-and hospital-level risk factors to the odds of 30-day readmissions as they only contained age and medical comorbidities as independent variables. We did not include patient race/ethnicity, gender, insurance status, or hospital characteristics in the models because such an adjustment may obscure factors that inappropriately influence the quality of care across hospitals.
Using empirical Bayesian posterior estimates from the logistic regression model, we determined the predicted 30-day readmission rate (risk and reliability adjusted) and 95% CIs at the hospital level for an average hospitalization and displayed the ranked order of adjusted rates across hospitals in a caterpillar plot (27) (28) (29) . We used the variance component for the hospital random effect to evaluate the statistical significance of the variation in 30-day readmission rates across hospitals (p < 0.05 for statistical significance). All data analyses were performed using JMP version 11.0 (SAS Institute, Cary, NC) and SAS for Windows version 9.4 (SAS Institute, Cary, NC).
RESULTS
Baseline Characteristics
A total of 368,514 hospitalizations for sepsis were identified from 325 hospitals for analysis in the HCUP SID database from 2009 to 2011. After excluding hospitalizations with age less than 18 (n = 6,163), missing length of stay (n = 55) and patient identifier number (n = 17,715), out-of-state residents (n = 4,368), admissions to rehabilitation or psychiatric facilities (n = 2,585), discharges in December (n = 34,157), transfers to another acute care hospital (n = 17,174), and in-hospital death (n = 58,928), there were 240,198 index hospitalizations available for analysis. The baseline characteristics of index hospitalizations for sepsis, CHF, and AMI are shown in the Supplemental There were some notable differences in baseline characteristics of index hospitalizations for sepsis versus CHF and AMI (Supplemental Table 2 , Supplemental Digital Content 1, http://links.lww.com/CCM/B362). Sepsis hospitalizations had a higher proportion of patients with dementia and malignancy as comorbidities, resulted more frequently in hospital discharge to a skilled nursing facility (39.9% for sepsis vs 17.2% and 14.0% for CHF and AMI, respectively), and had longer length of stay (6 d; IQR, 3-10 d vs 3 d; IQR, 2-6 d for both CHF and AMI).
Readmission Rates and Costs
The all-cause 30-day readmission rate for sepsis during the study period was 20.4% ( Table 1) 90-day readmission rates for sepsis during 2009-2011 are shown in Figure 1 . The average rate of readmission per day was 1.1% for days 1-7, 0.8% for days 7-14, 0.5% for days 14-30, and 0.2% for days 30-90. The 30-day readmission rates were 12.6%, 19.7%, and 29.2% among hospitalizations, resulting in a routine discharge home, a discharge with home healthcare, and discharge to a skilled nursing facility, respectively.
The 30-day readmission rates following hospitalizations for CHF and AMI were 23.6% and 17.7%, respectively (Table 1) . Median lengths of stay and in-hospital mortality were greater for sepsis than for CHF and AMI (Table 1) . From 2009 through 
Hospital-Level Variation in 30-Day Readmissions
There were 346 California hospitals eligible for the study in the dataset. After excluding hospitals with less than 10 annual hospitalizations for each diagnosis, 325 hospitals for sepsis, 328 hospitals for CHF, and 287 hospitals for AMI were included in the variability analysis. The risk-and reliability-adjusted readmission rates for sepsis ranged from 11.0% to 39.8% (median, 19.9%; IQR, 16.1-26.0%) and varied significantly across hospitals (p < 0.001). As an example of the magnitude of variation in readmissions across hospitals, the adjusted rates for hospitals 1 sd above versus below the mean were 33.7% (95% CI, 33.0-34.5) versus 13.0% (95% CI, 12.7-13.3), respectively. Hospitals in the 90th percentile were 2.5 times more likely to have a 30-day readmission for sepsis than those in the lowest 10th percentile (34.0% vs 13.8%). This variation is shown in the caterpillar plot where each hospital was ranked according to their risk-adjusted rate of 30-day readmissions following hospitalization for sepsis, CHF, and AMI (Fig. 2) . The overall variation between hospitals for sepsis and CHF were similar (Fig. 2) . Hospitals had higher variability in 30-day readmission rates for AMI compared with sepsis and CHF (Fig. 2) .
Diagnoses on Readmissions
Septicemia was the most common diagnosis on 30-day readmission following sepsis and comprised 29.2% of the readmissions (Supplemental Table 5 , Supplemental Digital Content 1, http://links.lww. com/CCM/B362). Pneumonia (4.8%) and respiratory failure (4.1%) were the next most common diagnoses (Supplemental Table 5 , Supplemental Digital Content 1, http://links.lww.com/CCM/B362). The distribution of the most common clinical diagnosis categories for 30-day readmissions following sepsis is summarized in Figure 3 . Infections accounted for 59.3% of the primary diagnoses on readmission at 30 days following an index hospitalization ( Fig. 3) . Frequencies of the diagnoses and clinical categories for 7-, 14-, 30-, and 90-day readmissions are shown in Supple associated with lower odds of 30-day readmission (OR, 0.87; 95% CI, 0.86-0.89; compared with male). Hospital-level characteristics most strongly associated with 30-day readmissions included hospitalizations at an institution delivering healthcare to the highest proportion of minorities (OR, 1.28; 95% CI, 1.23-1.34; for quintile of hospitals that had the highest proportion of minorities compared with the lowest quintile) and forprofit (OR, 1.34; 95% CI, 1.31-1.38) or university (OR, 1.35; 95% CI, 1.26-1.44) hospitals. By contrast, hospitalizations for sepsis in public hospitals were less likely to have 30-day readmissions compared with nonprofit hospitals (OR, 0.85; 95% CI, 0.82-0.89). The c-statistic of the sepsis model was 0.68.
Patient-and Hospital-Level Factors Associated With 30-Day Readmission
The patient-and hospital-level variables that were associated with higher odds of 30-day readmissions were generally similar between sepsis and CHF (Supplemental Table 6 , Supplemental Digital Content 1, http://links.lww.com/CCM/ B362). By contrast, there was a stronger association between hospital-level characteristics, including hospital size, teaching status, and proportion of minority patients, and 30-day readmissions for AMI than for sepsis or CHF (Supplemental Table 6 , Supplemental Digital Content 1, http://links.lww.com/ CCM/B362).
Sensitivity Analysis
Using the Angus implementation to identify hospitalizations for severe sepsis, the all-cause 30-day readmission rate in 2011 was 23.3% (Supplemental Table 8 , Supplemental Digital Content 1, http:// links.lww.com/CCM/B362). The number of sepsis cases in 2011 that were identified by the Angus implementation was greater than by the Martin implementation (236,932 vs 119,342 cases, respectively). As a result, the annual cost of sepsis readmissions was greater using the Angus implementation compared with the Martin implementation ($1.6 billion vs $612 million, respectively). The patient-and hospital-level factors that were associated with 30-day readmissions were similar between the Martin and Angus implementations (Supplemental Table 9 , Supplemental Digital Content 1, http:// links.lww.com/CCM/B362).
DISCUSSION
Recent reports from the AHRQ showed that the U.S. healthcare system spends more money on hospitalizations for sepsis than any other cause (10, 30) . The Medicare Payment Advisory Commission estimated that 75% of rehospitalizations may be avoidable and contribute to over $10 billion in excess healthcare costs for Medicare patients alone (31) . In this study, we used a large statewide database to show that about 20% of hospitalizations for sepsis result in readmission within 30 days of hospital discharge. This rate is similar to other high-risk medical conditions, such as CHF (23%) and AMI (18%). However, when one accounts for its higher prevalence, the total cost of 30-day readmissions for sepsis was greater than that for CHF and AMI combined; from 2009 to 2011, the annual cost of 30-day readmissions for sepsis in California was approximately $500 million/yr, more than twice that for CHF ($229 million/yr) and over three times that for AMI ($143 million/yr). These findings show that sepsis is a leading contributor to excess healthcare costs due to hospital readmissions.
In addition to the high cost, we observed wide variation in the rates of 30-day readmissions following sepsis between hospitals despite adjusting for case-mix. Hospitals in the 90th percentile were 2.5 times more likely than those at the 10th percentile to have a 30-day readmission after hospitalization of a comparable patient. This range of variability in readmission rates between hospitals for sepsis is similar to that of CHF. These findings suggest that, like CHF, important institutional factors are contributing to differences in readmission rates and imply that examining the differences between high-and lowperforming hospitals may inform the development of interventions at the policy and clinical levels to improve the quality of care.
Our study provides some context from which interventions that reduce readmissions for sepsis can be conceptualized. Previous studies showed that interventions that focus on the most prevalent causes of readmissions and target patients at highest risk for readmission are likely to have the greatest efficacy (1, (32) (33) (34) (35) (36) . Our analysis shows that when readmissions occur following sepsis, nearly 30% are due to another episode of sepsis and 60% are due to infections. These findings are consistent with a recent study by Ortego et al (12) in which 29 out of 63 (46%) patients who survived hospitalization for septic shock were readmitted within 30 days due to an infectionrelated cause. Nearly 40% of patients who were hospitalized for sepsis in our study were discharged to skilled nursing facilities. Thus, it is likely that any interventions that are hospital-based and do not include collaborative efforts with skilled nursing facilities will have limited efficacy. Notably, patients who were hospitalized with sepsis were also more likely to have comorbidities, such as dementia and malignancy, in which appropriate interventions may not be improvements in medical management or transitions in care, but instead patient-centered discussions that define the appropriateness of aggressive care, including rehospitalization. The findings from our study suggest that patients and families should be apprised of both the high morbidity in sepsis and the likely range of outcomes among survivors, including the high probability of extended morbidity resulting in rehospitalization and convalescence in skilled nursing facilities. Understanding these potential outcomes will allow patients, families, and healthcare providers to make the most informed choices regarding the care of patients with sepsis.
Our findings are consistent with 1) the report of a 30-day readmission rate of 26.5% in a nationally representative sample of 1,083 Medicare patients hospitalized for severe sepsis by Prescott et al (10) , 2) the study by Liu et al (9) that identified a 30-day readmission rate of 17.9% following sepsis among patients enrolled in a large California health maintenance organization, and 3) the report of a 30-day readmission rate of 23.4% among survivors of septic shock from a single academic medical center by Ortego et al (12) . We extend the findings of these studies by showing that in a large, diverse all-payer population, the impact of sepsis readmissions on the healthcare expenditure far exceeds that of other high-risk conditions that are current targets of hospital-and policy-level interventions. Many risk factors for readmissions identified in our study, such as minority race/ethnicity and Medicare payment status, were present across all three medical conditions that were examined and support the existing medical literature on rehospitalizations following AMI, CHF, and CAP (37) (38) (39) . The consistency of our findings with these studies supports the validity of our results and suggests that many risk factors for readmission are not unique to sepsis but instead affect the likelihood of rehospitalization regardless of the underlying diagnosis.
There are some limitations to consider when interpreting the findings of our study. First, we used claims data to identify cases of sepsis, readmission rates, and diagnoses on readmissions. Although there is a lack of literature that examines the accuracy of ICD-9 coding comparing CHF and AMI with sepsis, we used case definitions and clinical classification methods, which have been previously validated in order to minimize potential biases associated with the use of administrative data (7, 17) . The Martin implementation was used in our study because it accurately identifies hospitalizations for sepsis with a bias toward underestimating the number of cases (7) . Because we compared the cost of sepsis readmissions relative to CHF and AMI, using a coding scheme that underestimates the number of sepsis hospitalizations was the most conservative approach. The sensitivity analysis using the Angus implementation to identify cases of severe sepsis showed greater than a two-fold increase in the total number and annual cost of sepsis readmissions. These differences highlight the difficulty of accurately estimating the number of sepsis hospitalizations. Such discrepancies may be further complicated by changing coding practices for sepsis and the fact that sepsis remains a challenging diagnosis for clinicians. Despite these limitations, the sensitivity analysis suggests that the impact of sepsis on the overall problem of hospital readmissions may be even greater than presented in our study, further supporting our interpretation of the need to include sepsis among the conditions targeted to improve the readmissions problem. Second, the data were derived from the state of California and may not translate to other healthcare environments. However, the consistency of our results with other studies that have examined healthcare utilization in sepsis using national databases and from hospitals outside California supports the generalizability of our findings (10, 12, (37) (38) (39) . Finally, although we identified the most common causes of readmissions following sepsis and some associated risk factors, these associations do not explain the underlying mechanisms through which these rehospitalizations occur. Future studies will need to closely examine the causative events that lead to sepsis readmissions and to differentiate whether they occur as a result of substandard care during the index hospitalization or due to patientrelated factors that predispose to rehospitalization irrespective of the quality of care. This is an important direction for future studies as certain patient characteristics, such as Black and Native American race and lower income, portend a higher risk of readmissions, suggesting disparities in the quality of care that is being delivered. Understanding the contribution of these factors will also lead to a greater understanding of mutability of sepsis readmissions and the types of interventions that would be most effective.
CONCLUSION
The findings of our study highlight the centrality of sepsis to the problem of hospital readmissions. If future studies and policies that seek to improve the quality and efficiency of healthcare by reducing hospital readmissions are to be effective, they will need to address the problem of readmissions for sepsis, at least on a comparable level to CHF and AMI.
